According to Gram Research analysis of FDA data from 2010 to 2026, manufacturing quality problems affect 70% of drugs, 21% of cosmetics, and 9% of dietary supplements. Chemical contamination, procedural failures, and microbial contamination together cause 78% of all manufacturing issues. The FDA’s surveillance system catches these problems, but irregular spikes in reported issues suggest that detection depends partly on inspection intensity and agency resources.

Researchers examined 16 years of FDA safety records to understand why healthcare products, cosmetics, and supplements get pulled from shelves. They found that drugs had the most problems, with contamination and testing failures being the biggest issues. Cosmetics were mainly affected by unwanted chemicals and impurities, while supplements struggled with germs and contamination. The study shows that manufacturing problems happen in clusters rather than spreading evenly over time, suggesting that FDA oversight and funding may play a role in catching these issues.

Key Statistics

A 2026 analysis of FDA records from 2010 to 2026 found that drugs accounted for 70% of manufacturing quality issues, while cosmetics represented 21% and dietary supplements represented 9% of the 195 identified problems across 184 unique products.

Chemical contamination, procedural or testing failures, and microbial contamination together comprised 78% of all manufacturing quality issues identified in the FDA’s 16-year surveillance data, according to research published in The Annals of Pharmacotherapy.

An FDA data analysis covering 266 product entries from 2010 to 2026 revealed that manufacturing quality problems clustered in certain years, with notable spikes in 2020, 2022, 2024, and 2025, suggesting that detection rates depend on surveillance intensity.

Particulate contamination, the presence of visible particles or debris in products, occurred exclusively in drugs and never appeared in cosmetics or dietary supplements, according to the 16-year FDA surveillance review.

The Quick Take

  • What they studied: What types of manufacturing problems cause the FDA to recall or warn about drugs, cosmetics, and dietary supplements, and how often these problems occur.
  • Who participated: The study analyzed 266 FDA records of recalled or flagged products from June 2010 through May 2026. This included 184 unique products with confirmed manufacturing quality issues across three categories: medications, cosmetics, and dietary supplements.
  • Key finding: Drugs accounted for 70% of manufacturing problems, cosmetics for 21%, and dietary supplements for 9%. Chemical contamination, procedural failures, and microbial contamination together caused 78% of all issues identified.
  • What it means for you: Manufacturing problems in consumer products are real but appear to be caught by the FDA. However, the irregular pattern of recalls and the potential for reduced FDA funding suggest that oversight could improve to catch more problems earlier.

The Research Details

Researchers looked at two FDA databases that track product safety problems from June 2010 to May 2026. They examined 266 product entries and identified 195 specific manufacturing quality issues across 184 different products. The team sorted these problems by product type (drugs, cosmetics, or supplements) and then categorized each problem based on what went wrong during manufacturing. They reviewed official FDA warning letters and reports to understand the exact nature of each quality issue. This approach allowed them to see patterns in what types of problems affect different product categories and whether the number of problems changed over the 16-year period.

By analyzing actual FDA records rather than conducting new experiments, researchers could see real-world patterns in manufacturing failures across many products and years. This type of study is valuable because it shows what problems actually reach the FDA’s attention and get documented, helping identify which product types need the most oversight and what kinds of manufacturing mistakes are most common.

This study has several strengths: it covers 16 years of data, includes hundreds of products, and uses official government records that are reliable. However, the study depends on FDA reporting, which may be incomplete or inconsistent. The researchers note that budget cuts to the FDA and changes in how thoroughly the agency inspects facilities could affect which problems get caught and reported. The irregular spikes in reported issues (in 2020, 2022, 2024, and 2025) suggest that reporting practices or inspection intensity may vary from year to year rather than reflecting actual changes in manufacturing quality.

What the Results Show

Drugs were by far the most common products with manufacturing problems, accounting for 70% of all issues found. Within drugs, the main problems were procedural failures (like improper testing or quality control steps), chemical contamination (unwanted chemicals getting into the product), and microbial contamination (germs or bacteria). Cosmetics made up 21% of problems, with elemental impurities (unwanted metals or minerals) and chemical contamination being the most frequent issues. Dietary supplements and similar products accounted for 9% of problems, primarily involving microbial contamination, procedural failures, and elemental impurities. One notable finding was that particulate contamination (visible particles or debris in the product) only occurred in drugs, never in cosmetics or supplements. Overall, three types of problems dominated across all product categories: chemical contamination (30% of all issues), procedural or testing failures (29%), and microbial contamination (19%). Together, these three categories explained 78% of all manufacturing quality issues identified in the study.

The study revealed that manufacturing problems did not occur at a steady rate over the 16-year period. Instead, problems clustered in certain years, with notable spikes in 2020, 2022, 2024, and 2025. The researchers suggest that these spikes may reflect changes in FDA surveillance intensity, reporting practices, or inspection frequency rather than actual increases in manufacturing failures. This pattern indicates that the number of problems caught depends partly on how actively the FDA is monitoring and inspecting facilities.

This research provides a comprehensive overview of manufacturing quality issues using actual FDA data, which complements previous studies that examined specific product categories or types of contamination. The finding that drugs dominate quality issues aligns with the fact that medications are more heavily regulated and inspected than cosmetics or supplements. The identification of three main problem categories (chemical contamination, procedural failures, and microbial contamination) gives a clearer picture of where manufacturing processes most often fail.

The study relies entirely on FDA records, which means it only captures problems the agency detected and documented. Many manufacturing issues may go undetected, especially if companies do not report them or if the FDA does not inspect a facility. The researchers note that inconsistent FDA reporting practices and fluctuations in surveillance activity make it difficult to determine whether spikes in reported issues reflect actual increases in problems or simply more active monitoring. Additionally, the study does not examine why manufacturing problems occur or how to prevent them. Budget constraints at the FDA could mean fewer inspections and less detection of problems in the future.

The Bottom Line

Consumers should remain aware that manufacturing problems in drugs, cosmetics, and supplements do occur, but the FDA’s surveillance system catches many of them. Check FDA recall databases before purchasing products, especially if you have concerns about a specific brand. For prescription medications, ask your pharmacist about any recent recalls. For over-the-counter products and supplements, look for products from manufacturers with good safety records. These recommendations are based on solid evidence from 16 years of FDA data.

Everyone who uses medications, cosmetics, or dietary supplements should be aware of this research. People taking prescription drugs should be especially attentive, since drugs account for 70% of manufacturing problems. Those using dietary supplements or cosmetics should also stay informed, though problems are less frequent in these categories. Healthcare providers and pharmacists should use this information to counsel patients about product safety and the importance of checking for recalls.

Manufacturing problems are typically caught and acted upon by the FDA within months to a year of when they first occur, though some issues may take longer to detect. Consumers may notice recalls announced on the FDA website or through news reports. The irregular pattern of recalls suggests that detection timing depends on FDA resources and inspection schedules, which can vary.

Frequently Asked Questions

What are the most common manufacturing problems in medications and supplements?

Chemical contamination, procedural failures in quality testing, and microbial contamination are the three most common manufacturing problems, together accounting for 78% of all issues. Drugs most often have procedural and testing failures, while supplements are more likely to have microbial contamination.

How often does the FDA catch manufacturing problems in products?

The FDA identified 195 manufacturing quality issues across 184 products over 16 years. However, detection rates vary by year, with spikes in 2020, 2022, 2024, and 2025. The actual number of problems may be higher if some issues go undetected due to limited FDA inspection resources.

Are cosmetics and supplements safer than drugs when it comes to manufacturing?

Cosmetics and supplements have fewer reported manufacturing problems than drugs (21% and 9% respectively, compared to 70% for drugs), but this may partly reflect less intensive FDA oversight. Drugs are more heavily regulated and inspected, so more problems are likely to be caught and reported.

What should I do if a product I use gets recalled?

Stop using the product immediately and check the FDA’s official recall notice for specific instructions. Most recalls advise returning the product to the store or disposing of it safely. Contact your doctor or pharmacist if you have concerns about health effects from using the recalled product.

Could FDA budget cuts lead to more manufacturing problems going undetected?

Yes, the researchers note that reduced FDA funding could decrease inspection frequency and surveillance intensity, potentially allowing more manufacturing problems to slip through undetected. The irregular pattern of reported issues suggests that detection depends partly on agency resources.

Want to Apply This Research?

  • Set up weekly reminders to check the FDA’s official recall database for any products you regularly use. Track the product names, manufacturers, and recall dates in a simple list within the app to monitor whether brands you trust have had safety issues.
  • When purchasing medications, cosmetics, or supplements, use the app to quickly search the FDA database before buying. If a product you use is recalled, the app can help you document the issue and track whether you experienced any problems from using it.
  • Create a personal inventory of your regular medications, supplements, and cosmetic products in the app. Set monthly reminders to cross-reference this list against the FDA’s latest recalls and safety alerts. This ongoing monitoring helps you catch problems early if a product you use is flagged.

This research analyzes FDA surveillance data and does not constitute medical advice. If you believe you have been harmed by a recalled product, contact your healthcare provider immediately. Always consult with a doctor or pharmacist before starting, stopping, or changing any medication or supplement. For the most current product recalls and safety information, visit the official FDA website at fda.gov. This article is for informational purposes only and should not replace professional medical guidance.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Manufacturing Quality Issues in Healthcare and Cosmetics: An Analysis of FDA Surveillance Data. , The Annals of pharmacotherapy (2026). PubMed 42870453 | DOI
Topics
FDA recalls manufacturing quality drug contamination product safety cosmetic safety dietary supplement recalls microbial contamination chemical contamination